title: [Nitroglycerin patch for tocolysis--a prospective randomized comparison with fenoterol by infusion].
abstract: OBJECTIVE
  To evaluate tocolytic efficacy of transdermal glyceryl trinitrate (GTN) in comparison to fenoterol per infusionem in a prospective randomized multicenter study.
  
  
  METHODS
  50 pregnant women between 27 and 35 weeks of gestation with preterm labour were treated with either GTN patches (0.4-0.8 mg/h) or fenoterol per infusionem (60-120 micrograms/h) up to stop of contractions or 35 weeks in maximum. The primary outcomes were the prolongation of gestation by 48 h, 7 days or up to 37 weeks of gestation as well as the neonatal outcome. The progression of cervical ripening and maternal side effects during tocolysis were assessed as secondary outcome criteria.
  
  
  RESULTS
  There was no difference in successful tocolysis for 48 h and 7 days in both groups, whereas significantly more women passed 37 weeks after GTN therapy. So mean duration of pregnancy, birth weight and height were greater, whereas transfer into neonatal care unit was significantly rare after GTN. There were no differences in neonatal outcome and progression of cervical ripening during tocolysis. Maternal side effects during GTN were fewer and weaker compared with fenoterol. Circa 70% of GTN treated women had a headache temporary, whereas more than 90% of the patients with fenoterol suffered from tachycardia and tremor.
  
  
  CONCLUSIONS
  Tocolytic efficacy of transdermal GTN was at least equivalent to the established beta-mimetic therapy with fenoterol. Because of the lower preterm delivery rate transfer into neonatal care for control was significantly rarer after GTN with equally good neonatal outcome in both groups. Beside the headache transdermal GTN therapy had lower maternal side effects in comparison to fenoterol.
authors.affiliation: Klinik für Frauenheilkunde und Geburtshilfe, Abteilung Geburtshilfe, Klinikum der Friedrich-Schiller-Universität Jena. ekkehard.schleussner@med.uni-jena.de
authors.forename: E
authors.initials: E
authors.lastname: Schleussner
authors.forename: S
authors.initials: S
authors.lastname: Richter
authors.forename: W
authors.initials: W
authors.lastname: Gross
authors.forename: C
authors.initials: C
authors.lastname: Kähler
authors.forename: A
authors.initials: A
authors.lastname: Möller
authors.forename: U
authors.initials: U
authors.lastname: Möller
authors.forename: H J
authors.initials: HJ
authors.lastname: Seewald
mesh_terms: D000279:Administration, Cutaneous; D000328:Adult; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D005280:Fenoterol / Q000008:administration & dosage* / Q000009:adverse effects; D005865:Gestational Age; D006801:Humans; D007231:Infant, Newborn; D007262:Infusions, Intravenous; D008297:Male; D005996:Nitroglycerin / Q000008:administration & dosage* / Q000009:adverse effects; D011247:Pregnancy; D011446:Prospective Studies; D015145:Tocolysis / Q000379:methods*; D015149:Tocolytic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D016896:Treatment Outcome
chemical_list: D015149:Tocolytic Agents; D005280:Fenoterol; D005996:Nitroglycerin